Form 6-K NIO Inc. For: Aug 03
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 UNDER
THE SECURITIES EXCHANGE ACT OF 1934
For the month of August 2026
Commission File Number: 001-38638
NIO Inc.
(Registrant’s Name)
Building 19,
No. 1355, Caobao Road, Minhang District
Shanghai, People’s Republic of China
(Address of Principal Executive Offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F x Form 40-F ¨
EXHIBIT INDEX
| Exhibit No. | Description | |
| 99.1 | NIO Inc. Provides July 2026 Delivery Update |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| NIO Inc. | |||
| By | : | /s/ Yu Qu | |
| Name | : | Yu Qu | |
| Title | : | Chief Financial Officer | |
Date: August 3, 2026
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Global Coffee Market Size Set to Reach $238.99 Billion by 2031 Driven by Premium Ground Blends and Climate-Resilient Cultivars – Mordor Intelligence
- Atopic Dermatitis Pipeline Landscape 2026: Late-Stage Candidates, MOA Trends, and Routes of Administration by DelveInsight | GSk, Nestle SA, Pfizer, Regeneron, Abbvie, Allergan, Bausch Health Company
- BlackRock Capital Allocation Term Trust (BCAT) Announces Results of its Rights Offering
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share